Delivery Order SPE2DB22D3016-SPE2DB25FAUA4

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a ceiling value of $8,900.03 and is a firm fixed price delivery order, with a period of performance through June 10, 2025. The contract is not set aside for any small business category....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The ceiling value of this delivery order is $7,892.64 and it has a firm fixed price pricing type. The contract has a performance period through September 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with a ceiling value of $7,064.98 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes, with a ceiling value of $9,681.62 and a completion date of August 21, 2024. The award is for a firm fixed-price delivery order, and the contract type is not set aside. Amerisourcebergen is the prime contractor, and the delivery order is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,472.95 firm fixed-price contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a medical product, with a completion date of January 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a ceiling value of $6,664.50 and is a firm fixed price type contract. The period of performance extends to May 14, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,884.86, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a firm fixed price, with a ceiling value of $8,322.43 and a period of performance through January 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the product "ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML" with a ceiling value of $3,152.40 and an ultimate completion date of January 23, 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds a larger $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a ceiling value of $7,708.63 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAUA4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with a ceiling value of $8,641.45. The contract is a firm fixed-price delivery order and is not set aside.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/16/25, 12:28 PM